These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36129699)

  • 1. The Effect of Anti-Inflammatory Topical Ophthalmic Treatments on In Vitro Corneal Epithelial Cells.
    Sella R; Cohen-Tayar Y; Noguchi T; Finburgh EN; Lian RR; Abbas AA; Hakim DF; Bu JJ; Zhao J; Shaw P; Bahar I; Afshari NA
    Transl Vis Sci Technol; 2022 Sep; 11(9):16. PubMed ID: 36129699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different cellular effects of four anti-inflammatory eye drops on human corneal epithelial cells: independent in active components.
    Qu M; Wang Y; Yang L; Zhou Q
    Mol Vis; 2011; 17():3147-55. PubMed ID: 22171161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of refractory cases of persistent epithelial defects associated with dry eye syndrome and recurrent corneal erosions successfully treated with cyclosporine A 0.05% eye drops.
    Napoli PE; Braghiroli M; Iovino C; Demarinis G; Fossarello M
    Drug Des Devel Ther; 2019; 13():2001-2008. PubMed ID: 31354245
    [No Abstract]   [Full Text] [Related]  

  • 4. Alleviation of dry eye syndrome with one dose of antioxidant, anti-inflammatory, and mucoadhesive lysine-carbonized nanogels.
    Lin PH; Jian HJ; Li YJ; Huang YF; Anand A; Huang CC; Lin HJ; Lai JY
    Acta Biomater; 2022 Mar; 141():140-150. PubMed ID: 35081433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro assessment of the cytotoxicity of anti-allergic eye drops using 5 cultured corneal and conjunctival cell lines.
    Ayaki M; Iwasawa A; Yaguchi S; Koide R
    J Oleo Sci; 2011; 60(3):139-44. PubMed ID: 21343662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
    Tauber J; Karpecki P; Latkany R; Luchs J; Martel J; Sall K; Raychaudhuri A; Smith V; Semba CP;
    Ophthalmology; 2015 Dec; 122(12):2423-31. PubMed ID: 26365210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent.
    Ubels JL; Clousing DP; Van Haitsma TA; Hong BS; Stauffer P; Asgharian B; Meadows D
    Curr Eye Res; 2004 Jun; 28(6):437-44. PubMed ID: 15512952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
    Sheppard JD; Torkildsen GL; Lonsdale JD; D'Ambrosio FA; McLaurin EB; Eiferman RA; Kennedy KS; Semba CP;
    Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
    Kim YJ; Ryu JS; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Oh JY
    Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement.
    Fukushima A; Ohashi Y; Ebihara N; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Namba K; Fujishima H; Miyazaki D
    Br J Ophthalmol; 2014 Aug; 98(8):1023-7. PubMed ID: 24695688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
    Strong B; Farley W; Stern ME; Pflugfelder SC
    Cornea; 2005 Jan; 24(1):80-5. PubMed ID: 15604871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease.
    Nichols KK; Donnenfeld ED; Karpecki PM; Hovanesian JA; Raychaudhuri A; Shojaei A; Zhang S
    Eur J Ophthalmol; 2019 Jul; 29(4):394-401. PubMed ID: 30112930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new ophthalmic formulation containing antiseptics and dexpanthenol: In vitro antimicrobial activity and effects on corneal and conjunctival epithelial cells.
    Mencucci R; Favuzza E; Bottino P; Mazzantini C; Zanotto E; Pellegrini-Giampietro DE; Landucci E
    Exp Eye Res; 2020 Dec; 201():108269. PubMed ID: 32980315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study.
    Donnenfeld ED; Karpecki PM; Majmudar PA; Nichols KK; Raychaudhuri A; Roy M; Semba CP
    Cornea; 2016 Jun; 35(6):741-8. PubMed ID: 27055211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifitegrast Ophthalmic Solution 5%: A Review in Dry Eye Disease.
    Keating GM
    Drugs; 2017 Feb; 77(2):201-208. PubMed ID: 28058622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro.
    Lee JS; Kim YH; Park YM
    J Korean Med Sci; 2015 Dec; 30(12):1856-64. PubMed ID: 26713063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological activities of an eye drop containing Matricaria chamomilla and Euphrasia officinalis extracts in UVB-induced oxidative stress and inflammation of human corneal cells.
    Bigagli E; Cinci L; D'Ambrosio M; Luceri C
    J Photochem Photobiol B; 2017 Aug; 173():618-625. PubMed ID: 28704790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Inflammatory and Antioxidative Effects of Camellia japonica on Human Corneal Epithelial Cells and Experimental Dry Eye: In Vivo and In Vitro Study.
    Lee HS; Choi JH; Cui L; Li Y; Yang JM; Yun JJ; Jung JE; Choi W; Yoon KC
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1196-1207. PubMed ID: 28245300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The in vitro effect of antiseptics on epithelial cells of human cornea and conjunctiva].
    Alexander-Sinclair EI; Okolov IN; Perepletchikova DA; Grechanaya YS; Zhurenkov KE; Blinova MI
    Vestn Oftalmol; 2021; 137(5):86-92. PubMed ID: 34726862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 0.025% FK-506, 0.05% Cyclosporin A, and 0.3% Sodium Hyaluronate Eye Drops for the Treatment of Botulinum Toxin B-Induced Mouse Dry Eye.
    Lin BW; Huang WL; Wang L; Chen ZM
    J Ocul Pharmacol Ther; 2018 Nov; 34(9):633-641. PubMed ID: 30227093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.